Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Spun out from IIT-Bombay in 2018, ImmunoACT is India's pioneer in the development of the country's first indigenous Cell and gene Therapy. With a rapidly expanding pipeline beginning with blood cancers, our mission is to provide affordable access to novel autologous CAR-T cell therapies.

List your booth number for exhibitions, ask us